Showing results (1271-1280 of 1,342) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|February 8, 2024
Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastomaSamuel A Goldlust, Louis B Nabors, Sigmund Hsu, et al.
Neuro-Oncology Advances|March 29, 2024
Preclinical evaluation of protein synthesis inhibitor omacetaxine in pediatric brainstem gliomasYongjuan Chen, Aaminah Khan, Christopher Katsinas, et al.
Neuro-Oncology Advances|March 29, 2024
Proton versus photon craniospinal irradiation for adult medulloblastoma: A dosimetric, toxicity, and exploratory cost analysisWilliam G Breen, Connie S Geno, Mark R Waddle, et al.
Neuro-Oncology Advances|February 26, 2024
Unsupervised machine learning models reveal predictive clinical markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiationWesley Wang, Zeynep Temerit Kumm, Cindy Ho, et al.
Neuro-Oncology Advances|January 31, 2024
TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcomaAiguo Li, John C Hancock, Martha Quezado, et al.
Neuro-Oncology Advances|April 26, 2024
Profiling the molecular and clinical landscape of glioblastoma utilizing the Oncology Research Information Exchange Network brain cancer databaseAlexandra N Demetriou, Frances Chow, David W Craig, et al.
Neuro-Oncology Advances|July 27, 2023
Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade gliomaJoshua D Bernstock, Sarah E Blitz, Samantha E Hoffman, et al.
Neuro-Oncology Advances|August 7, 2023
Surgery versus radiosurgery for vestibular schwannoma: Shared decision making in a multidisciplinary clinicFrancesca Colombo, Helen Maye, Scott Rutherford, et al.
Neuro-Oncology Advances|August 9, 2023
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomasMatthias Holdhoff, M Kelly Nicholas, Richard A Peterson, et al.
Neuro-Oncology Advances|March 19, 2026
A systematic review and meta-analysis of outcomes following active surveillance, surgery and radiotherapy of meningiomas in NF2-related schwannomatosisJack Sheppard, Siddarth Kannan, Jane Halliday, et al.
Pageof 135